Mifepristone is a key drug used in abortion treatment that was approved by the FDA over 20 years ago and is safer than Tylenol.
Now, the upcoming Supreme Court case could be the first time the conservative-majority Court will rule on abortion since it overturned Roe. It could not only radically change access to abortion care nationwide, but it could also drastically impact the FDA’s regulatory authority.
If the Court overturns the FDA's approval of the drug it will limit the option of treatment for those that need it, and it could put the FDA's regulatory authority severely at risk.
Sign the petition: Protect our access to reproductive health care–protect mifepristone!